Biblio

Found 5 results

Filters: Author is Schneider, Lon S [Clear All Filters]

2020

Wang Y, Hernandez G, Mack WJ, Schneider LS, Yin F, Brinton RD. 2020. Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy.. Menopause. 27(1):57-65.

2017

Geifman N, Brinton RDiaz, Kennedy RE, Schneider LS, Butte AJ. 2017. Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease.. Alzheimers Res Ther. 9(1):10.

Hernandez G, Zhao L, Franke AA, Chen Y-L, Mack WJ, Brinton RD, Schneider LS. 2017. Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor β-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women.. Menopause.

2013

Zhao L, Mao Z, Chen S, Schneider LS, Brinton RD. 2013. Early intervention with an estrogen receptor β-selective phytoestrogenic formulation prolongs survival, improves spatial recognition memory, and slows progression of amyloid pathology in a female mouse model of Alzheimer's disease.. J Alzheimers Dis. 37(2):403-19.

2011

Zhao L, Mao Z, Schneider LS, Brinton RD. 2011. Estrogen receptor β-selective phytoestrogenic formulation prevents physical and neurological changes in a preclinical model of human menopause.. Menopause. 18(10):1131-42.